Savient Pharmaceuticals, Inc. (NASDAQ: SVNT): After last week's success with their gout drug, these shares haven't stopped rising. They reached a new high of $21.36 against 52-week low of $10.58.

Trane Inc. (NYSE: TT): A nice big buy-out from Ingersoll-Rand Company Limited (NYSE: IR) sent shares up to $45.27 from 52-week low of $32.09.

Varian Medical Systems, Inc. (NYSE: VAR): The FDA approved new proton scanning product. The stock Traded up to $52.05 from 52-week low of $37.30.

Coca-Cola Enterprises Inc. (NYSE: CCE): Still moving up after last week's strong forecast. Hit $26.93, up from 52-week low of $18.78.

Douglas A. McIntyre is an editor at 247wallst.com.

With the credit crunch and the cooling of private equity, the M&A space has been fairly meager lately. But today, we got some good news (at least for deal junkies) -- Ingersoll-Rand (NYSE: IR) has agreed to pay $10.1 billion for Trane (NYSE: TT).

Ingersoll-Rand, founded in 1871, is a major diversified industrial company, with brands like Club Car golf cars, Hussmann stationary refrigeration equipment, and Schlage locks. And with the Trane deal, the company will boost its large climate control business, making it the #2 player behind United Technologies.

Funny enough, it seems that Trane was trying to market itself to private equity buyers by selling off divisions and streamlining divisions. But of course, such a company can also be attractive to a strategic buyer – especially as global markets remain highly competitive.

With the Trane deal, Ingersoll-Rand will have $17 billion in revenues and $2 billion in EBIT (earnings before interest and taxes).

Yet, Wall Street is a bit skeptical, with Ingersoll-Rand's stock price down 7%. Trane's stock, on the other hand, is up 23%.

Tom Taulli is the author of various books, including The Complete M&A Handbook and The Edgar Online Guide to Decoding Financial Statements. He also operates DealProfiles.com.

Trane (NYSE: TT) is recently up $2.12 to $37.96. TT has traded 20,000 calls and 3,000 puts. TT January option implied volatility of 75 is above its 26-week average of 35 according to Track Data, suggesting larger risk.

Options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

American Standard Companies (NYSE: ASD) is going through an extreme makeover. The company plans to spin off its Vehicle Control Systems division (which will be called WABCO) and wants to focus on its air condition business. So, the name of the reconstituted entity will be Trane (which generates about $6.8 billion in revenues).

To this end, today American Standard said it sold its Bath and Kitchen products unit to private equity firm, Bain Capital. The price tag: $1.76 billion, cash.

Actually, it looks like a good deal for Bain. The Bath & Kitchen unit posted $2.4 billion in revenues in 2006 and has a variety of brands like American Standard, Ideal Standard, Armitage Shanks, Porcher, Jado, Ceramica Dolomite and Vidima.

Then again, the unit has been under pressure lately. For example, increased commodities prices has been tough.

But, by being a private company – and independent of a major parent – there's likely to be some operational improvements.

American Standard retained Lazard (NYSE: LAZ) for its financial advisor. Lehman Brothers (NYSE: LEH) represented Bain.

In today's trading, American Standard's stock price was up $0.15 to $59.40.

To check out some more recent M&A transactions, click here.

Tom Taulli is the author of various books, including the Complete M&A Handbook and the EDGAR-Online Guide to Decoding Financial Statements.